FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3951060 · Received July 22, 2014

Report

Report Number
2124215-2014-11273
Event Type
Malfunction
Date Received
July 22, 2014
Date of Event
June 11, 2013
Report Date
October 8, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. ABRASIONS WERE NOTED THROUGH THE TRILUMEN INSULATION APPROXIMATELY 280-287 MILLIMETERS (MM) AND 196-202 MM FROM THE TERMINAL PIN. THE ABRASIONS WERE SMOOTH AND CONCAVE. DUE TO THE LOCATIONS AND TYPE OF DAMAGE THESE WERE LIKELY CAUSED BY LEAD-ON-LEAD CONTACT COUPLED WITH MOVEMENT. AN INSULATION ABRASION THROUGH TO A SENSING CONDUCTOR COULD CAUSE NOISE TO BE SEEN BY THE DEVICE. LABORATORY TESTING CONFIRMED THE REPORTED CLINICAL OBSERVATIONS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD REGISTERED MORE THAN 100 OF NOISE EPISODES. HOWEVER, AMPLITUDE, IMPEDANCE AND THRESHOLD MEASUREMENTS WERE WITHIN NORMAL RANGE. A LEAD REVISION WAS PERFORMED TO REPLACE THIS LEAD. THE PATIENT¿S IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS ALSO REPLACED EVEN THE DEVICE WAS NOT YET IN ERI TO TAKE ADVANTAGE OF THE SURGICAL LEAD REVISION. THERE WAS NO ALLEGATION AGAINST THE ICD. NO ADVERSE PATIENT EFFECTS WERE REPORTED. THIS LEAD WAS SUCCESSFULLY REPLACED AND ALL FINAL MEASUREMENTS WERE OF NORMAL RANGE. THIS LEAD WILL BE RETURNED. ADDITIONAL INFORMATION RECEIVED AND CONFIRMED THAT THE NOISE RESULTED TO OVERSENSING; HOWEVER, THERE WAS NO PACING INHIBITION THAT LEAD TO ASYSTOLE AS THE PATIENT WAS NOT PACEMAKER DEPENDENT. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
427643 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1 0175| 0695| F140| T175